A Phase 2 study demonstrated the accuracy of lung cancer gene panel testing using cytological specimens, with a success rate of 100% and sufficient yield for analysis. The extracted nucleic acid quality was also adequate for panel analysis, enabling the detection of gene mutations in 68.1% of cases.
A study analyzing surgical tissue samples from patients with stage IIIA NSCLC found that high AKT expression and activated dendritic cells were associated with lower progression-free survival and overall survival. The immune expression signature identified could help follow-up and therapeutic management of high-risk patients.
Combining sotorasib with pembrolizumab or atezolizumab demonstrated durable clinical activity, lower treatment-related adverse events, and improved overall survival in patients with advanced KRAS p.G12C NSCLC. The study showed a higher incidence of grade 3-4 adverse events initially, but these effects may be mitigated by dose reduction.
Scientists at UC Berkeley develop a new COVID-19 therapeutic using antisense oligonucleotides (ASOs) that target a conserved region of the viral genome. The treatment is highly effective in preventing and treating COVID-19 infections in human cells and animal models, with no significant immune response.
QUT researchers have created a method to tell an autonomous vehicle which cameras to use when navigating, allowing for better understanding of the world around them. The system learns which cameras are most useful at different locations based on previous experience.
Researchers at Japan Advanced Institute of Science and Technology have developed a novel anode material consisting of black glasses grafted silicon microparticles, which shows great promise in enhancing lithium-ion battery performance and energy storage. The material exhibits high lithium diffusion ability, reduced internal resistance,...
The NELSON Trial demonstrated a 24% reduction in lung cancer mortality with low-dose CT screening, compared to the 20% found in the NLST. The new protocol used in NELSON showed improved sensitivity for early-stage cancers, increasing the benefits of lung cancer screening while reducing unnecessary follow-up procedures.
A world-first study reveals a direct link between low vitamin D and high inflammation, providing a biomarker for those at risk of chronic illnesses. Boosting vitamin D in people with deficiencies may reduce chronic inflammation.
The study observes electric gate-controlled exchange-bias effect in van der Waals heterostructures, enabling scalable energy-efficient spin-orbit logic. The team successfully tunes the blocking temperature of the EB effect via an electric gate, allowing for the EB field to be turned 'ON' and 'OFF'.
A new approach to studying cell binding has been developed, allowing for precise measurement of adhesion forces in various conditions. This technique, scRAFA, enables label-free and sub-cellular-resolution quantification of adhesion, with applications in fields such as cell biology, immunotherapy, and urinary tract infection.
Researchers discovered a new perspective on the tropical cyclone size-intensity relationship, finding that latitude and environmental vertical wind shear are primary influences. This reexamination sheds light on the physical mechanisms underlying coordinated changes within TCs, enabling better warning systems.
A new AI-rendering system leverages layered depth image representation to create high-quality phase-only 3D holograms in real-time on consumer desktops and cellphones. The system corrects vision aberrations and produces realistic depth boundaries, making holographic displays more accessible.
A recent study found that younger patients with lung cancer are more likely to be diagnosed at later stages, highlighting the need for strategies to increase early detection among younger adults. In contrast, older patients have seen improvements in earlier stage diagnoses since the onset of lung cancer screening.
Research presented at the IASLC World Conference on Lung Cancer 2022 found that increased utilization of Stereotactic Body Radiotherapy (SBRT) has decreased treatment disparities for early-stage non-small cell lung cancer (NSCLC). The study showed a significant increase in the proportion of patients receiving definitive treatment, with...
The IASLC Early Detection and Screening Committee report outlines the challenges of implementing lung cancer screening in low- and middle-income countries. The committee emphasizes the need for evidence-based guidelines, considering regional specificities and population-specific risk factors.
Researchers at Osaka Metropolitan University evaluated ACL reconstruction options and found that quadriceps tendon-patellar bone (QTB) grafts have greater similarity to the ACL at femoral insertion sites, indicating they are a more suitable option. This study contributes to potential improvement in ACL injury treatment by reducing the ...
A budget impact analysis shows that implementing the NELSON screening model in 28 European countries could prevent over 18,000 premature lung cancer deaths. The model estimates a total budget impact of approximately €937 million if half of the eligible population is screened.
A phase 3 trial showed sugemalimab improved progression-free survival (PFS) by 69% compared to placebo, with a median PFS of 10.5 months. Overall survival (OS) data also suggested a trend towards benefit favoring sugemalimab.
Researchers found that 7-month-old infants quickly discriminate between symmetrical and asymmetrical mosaics, indicating a robust ability to detect structural symmetry. This skill coincides with those found in studies using other stimuli, suggesting babies are good at extracting structure and rules from various media.
A study presented at the IASLC World Conference on Lung Cancer 2022 found four molecular subtypes of non-small cell lung cancer (NSCLC) driven by MET exon 14 skipping, each with distinct clinical characteristics and responses to treatment.
Researchers found that second primary lung cancer occurs in approximately 4% of lung cancer patients, with a higher rate of up to 8% among those undergoing surgery for early-stage disease. The study also revealed variations in incidence rates by treatment type and stage.